Clean Science & Technology Ltd is a leading Indian manufacturer of specialty chemicals, producing high-value, functionally critical products used in pharmaceuticals, agrochemicals, polymers, and FMCG sectors. Headquartered in Aurangabad, the company exports to over 45 countries and holds global leadership positions in key molecules like MEHQ, BHA, and AP. With a debt-free balance sheet, industry-leading ROCE (~29%), and consistent profit growth, Clean Science has emerged as a high-quality compounder in the chemical space. However, its premium valuation demands disciplined entry. This article provides a realistic outlook and share price targets for each year from 2026 to 2030, based on fundamentals and sector dynamics.
Based on high ROCE, export strength, and product diversification, but tempered by rich valuation, we project:
Year
Target Price Range (₹)
2026
₹840 – ₹940
2027
₹900 – ₹1,020
2028
₹960 – ₹1,120
2029
₹1,020 – ₹1,220
2030
₹1,080 – ₹1,320
These targets assume:
EPS CAGR of 16–18% (supported by 18% recent profit growth)
P/E range of 28–32x (slight compression from current 31.2x)
Sustained ROCE >28% and zero debt
Year-wise Breakdown
Clean Science Share Price Target 2026
Year
Target 1
Target 2
2026
₹840
₹940
Rationale: Near-term upside supported by new capacity ramp-up and long-term client contracts. Current P/E of 31x is fair for quality.
Clean Science Share Price Target 2027
Year
Target 1
Target 2
2027
₹900
₹1,020
Rationale: Expected benefit from new molecule commercialization (e.g., DCC, Anisole derivatives) and geographic diversification.
Clean Science Share Price Target 2028
Year
Target 1
Target 2
2028
₹960
₹1,120
Rationale: By 2028, operating leverage from scale could push ROCE above 30%. Margin resilience supports premium.
Clean Science Share Price Target 2029
Year
Target 1
Target 2
2029
₹1,020
₹1,220
Rationale: Long-term play on India’s specialty chemical export boom and import substitution in regulated markets.
Clean Science Share Price Target 2030
Year
Target 1
Target 2
2030
₹1,080
₹1,320
Rationale: The upper end assumes sustained 20%+ ROE, market leadership in niche molecules, and peer-average P/B (6–7x).
Strengths vs Risks
✅ Strengths
Debt-free with strong cash flow
Global #1/#2 in multiple specialty chemicals
High ROCE (29.3%) and ROE (21.9%)
Consistent dividend payer (0.75% yield)
⚠️ Risks
Valuation premium (P/E 31x, P/B 5.3x)
Concentration risk in a few high-value molecules
Regulatory risks in EU/US chemical approvals
Low public float (19.26%) can cause volatility
Investment Suitability
Factor
Assessment
Risk Profile
Moderate (quality mid-cap)
Time Horizon
Long-term (5+ years)
Volatility
Moderate
Dividend/Income
Low but consistent
Ideal Investor
Quality-focused investor bullish on India’s chemical export story
FAQs
A realistic range is ₹840 – ₹940, assuming steady execution and no major global slowdown.
By 2030, it could reach ₹1,080 – ₹1,320 if new products gain traction and margins hold.
No—those levels are unrealistic. The stock trades above ₹790, so ₹40/₹50 likely confuses face value (₹1) with market price.
The Kanoria promoter family holds 50.96% of shares and controls the company.
Yes—it has a consistent dividend history with a current yield of 0.75% and ~20% payout ratio.
Due to valuation concerns, global chemical cycle slowdown, and profit-taking after past rallies, not fundamental weakness.
Yes—for quality-focused investors who believe in India’s specialty chemical leadership and can tolerate moderate volatility.
Final Verdict
Clean Science & Technology is a high-quality, debt-free specialty chemical player with global relevance and pricing power. While its valuation is premium, its ROCE, export strength, and product moat justify a long-term holding. Our 2026–2030 price targets (₹840–₹1,320) reflect steady, sustainable appreciation—not speculative hype. Investors should consider accumulating on dips with a 5-year horizon.
📌 Disclaimer: Price targets are estimates based on current fundamentals and sector trends. They are not investment advice. Please consult a SEBI-registered advisor.
Hi, I’m Raj Mittal, a stock market content writer focused on company analysis, share price trends, and fundamental research. I create simple, research-based insights to help investors make smarter market decisions.
